Document › Details
Bruker Corporation. (6/6/16). "Press Release: Bruker Introduces Innovative timsTOF Mass Spectrometer". San Antonio, TX.
|Region||San Antonio, TX|
|Country||United States (USA)|
|Organisation||Bruker Daltonics (Operating Business of Bruker Corporation)|
|Group||Bruker Corporation (Group)|
|Organisation 2||Florida State University (FSU)|
|Product||timsTOF™ mass spectrometer|
|Product 2||ASMS 2016 San Antonio|
|Index term||DSM–Bruker Corp: mass spectrometer, 201606 supply existent DSM Resolve early user of timsTOF system|
|Index term 2||Univ Rouen–Bruker Corp: mass spectrometer, 201606 supply existent Univ Rouen early user of timsTOF system|
|Person||Park, Melvin (Bruker 201606 Director of Research at Bruker Daltonics)|
|Person 2||Bleiholder, Christian (Florida State Univ 201606 Professor at Dept of Chemistry + Biochemistry)|
Unique Trapped Ion Mobility Spectrometry (TIMS) Coupled to Bruker's High-Performance QTOF Mass Spectrometry Enables High-Resolution Compound Separation, Significant Duty Cycle Enhancements and Studies of Protein Conformations, Aggregation and Structural Isomers
At the 64th ASMS Conference, Bruker introduces an entirely new mass spectrometry technology platform: the innovative timsTOF™ system combines very high ion mobility resolution greater than 200, using Bruker's proprietary Trapped Ion Mobility Spectrometry (TIMS), with Bruker's ultra-high performance ESI-QTOF mass spectrometry.
The new timsTOF is a flexible, research-grade instrument for optimal separation and analysis of unresolved compounds and conformations. Bruker's unique Ion Mobility Expansion (imeX™) TIMS technology empowers market-leading, highest ion mobility resolution that can be adjusted to research or analytical needs. A novel Open Data Format supports user-created software tools tailored to specific research questions.
In recent years, ion mobility separation has matured into a valuable analytical tool that boosts mass spectrometry analysis in various areas. Ion mobility resolution, however, has been restricted in previous IMS systems by physical size limitations. Bruker's completely unique and proprietary timsTOF system eliminates these trade-offs and limitations with the extremely powerful, yet very compact TIMS device that achieves market-leading ion mobility resolution greater than 200 for unparalleled separation and IMS research power.
Dr. Melvin Park, Director of Research at Bruker Daltonics, who has overseen the research of timsTOF since its inception, has collaborated with key customers to incorporate further TIMS refinements and develop advanced TIMS applications. Dr. Park stated: "The all-new timsTOF system takes ion mobility performance to the next level. Years of experience in the application of TIMS design and solid engineering are merged in this novel instrument to set new standards in ion mobility resolution. Our collaborators and timsTOF customers will experience unprecedented research flexibility and exceptional analytical confidence."
Professor Christian Bleiholder in the Department of Chemistry & Biochemistry at Florida State University in Tallahassee, FL, added: "Our work focuses on native structure elucidation of proteins and on studying protein-ligand binding events by ion mobility spectrometry – mass spectrometry methods. The high ion mobility resolving power of our timsTOF system, which routinely exceeds 200, increases the confidence in the structural interpretation of our data. Also very important for our work is the ability of TIMS to preserve solution-phase structures, and the ability to trap analyte ions in the TIMS device to monitor structural changes over extended periods of time."
About the timsTOF system
The proprietary timsTOF system offers next-generation of ion mobility technology to enable the high-definition profiling of compounds and conformations in complex samples. In addition to Bruker's high-performance QTOF high mass resolution, ppm accurate mass and high isotopic fidelity (True Isotopic Pattern, or TIP™), TIMS allows separation of isomeric compounds, accurate determination of collisional cross sections and gas-phase protein structure and aggregation studies. Furthermore, fragmentation of TIMS-separated precursor ions results in clear fragmentation spectra for confident identifications.
Dr. Jan Jordens, at DSM Resolve in The Netherlands, commented: "The timsTOF gave us more insight into our samples through highest resolution LC-TIMS-MS/MS data right from the beginning. We saw information that we did not even expect. Now, the platform really helps us to get new knowledge about processes that are taking place in our samples and also about unexpected impurities."
Powered by Bruker's Ion Mobility Expansion (imeX) TIMS technology, the ion mobility resolution of the timsTOF system can be adjusted to examine compounds of interest in detail. This powerful TIMS flexibility enables novel workflows which leverage the unprecedented TIMS resolving power of greater than 200.
Sensitivity has been restricted in previous devices by the limited duty cycle, which means a significant loss of ions in commonly used ion mobility devices. The timsTOF system now enables ion mobility separation with up to 100% duty cycle based on its unique parallel accumulation capability. TIMS can be disabled in the timsTOF under software control without any loss of QTOF performance.
To maximize timsTOF research flexibility, the platform uses an Open Data Format (*.tdf) that supports tailored analyses based on open source SQLite, thus enabling users to develop their own analytical algorithms. With standardized structure and straightforward access, data from timsTOF are easily incorporated into innovative data processing, new forms of visualization and informative reports. The Bruker-supplied Data Analysis 5.0 software enables interactive analysis of high-resolution ion mobility data in heat maps, mobilograms, and mass spectra.
Dr. Carlos Afonso at the Université de Rouen in France commented: "We are already using ion mobility in our lab, but with the much higher ion mobility resolution that timsTOF provides now, there is a lot of room for different applications based on this novel technology."
About the Bruker Corporation
For more than 50 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific research instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.
In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics. For more information, please visit: www.bruker.com
[ picture / figure ]
Figure 1: Raffinose, Melezitose and Maltotriose have the same elemental composition C18H32O16, but differ in structure: A. timsTOF separates the isomeric trisaccharides with ion mobility resolution of 80. B. imeX technology allows adjusting ion mobility resolution which is increased to 120 in this acquisition. C. imeX ultra mode allows baseline separation of the trisaccharides with ion mobility resolution of 185.
Director, Marketing Solutions, Bruker Daltonics
T: 45 2633 2021
Director, Investor Relations, Bruker Corporation
T: 1 (978)-663-3660
Record changed: 2016-07-01
More documents for Bruker Corporation (Group)
-  Bruker Corporation. (3/6/17). "Press Release: Bruker Introduces New Scientific Instruments and Analytical Solutions at Pittcon 2017". Chicago, IL....
-  Bruker Corporation. (3/3/17). "Press Release: Alcami Invests in Bruker’s D8 Discover HTS System for High-Throughput X-Ray Diffraction Screening in Pharmaceutical Formulation Development". Weert & Karlsruhe....
-  Bruker Corporation. (2/27/17). "Press Release: Bruker Corporation to Present at Investor Conferences". Billerica, MA....
-  Bruker Corporation. (2/21/17). "Press Release: Bruker Announces Quarterly Dividend". Billerica, MA....
-  University of Warwick. (2/17/17). "Press Release: Molecular Phenomenon Discovered by Advanced NMR Facility"....
-  Bruker Corporation. (2/13/17). "Press Release: Bruker Reports Fourth Quarter and Fiscal Year 2016 Financial Results". Billerica, MA....
-  Albany Molecular Research, Inc.. (2/7/17). "Press Release: AMRI Announces Strategic Alliance to Advance Mass Spectrometry Capabilities for Drug Discovery". Albany, NY....
-  Bruker Corporation. (2/6/17). "Press Release: Bruker Introduces MALDI PharmaPulse 2.0 Solution at SLAS 2017 for 100x Faster Mass Spectrometry-Based, Label-Free Screening in Drug Discovery"....
-  Analytik Jena AG. (2/6/17). "Press Release: One Million Tests a Week – Analytik Jena Optimizes the Process for Ultra High Throughput Screening". Jena & Washington, DC....
-  Bruker Corporation. (1/30/17). "Press Release: Bruker and iTomography Corporation Announce License Agreement for iTomo Image Reconstruction Software". Kontich....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to email@example.com and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]